Arzneimittel-Atlas 2023

Valid information about the consumption of pharmaceuticals is essential for health and economic policy decisions. The Pharmaceutical Atlas has been providing transparent and structured information on the development of prescriptions covered by statutory health insurance (GKV) for over 15 years. This standard work examines the entire outpatient pharmaceutical market, highlights key areas, and presents the most important results of particularly dynamic indication groups in a clear format. The comprehensive view of the analyses is offered in the online version of the Pharmaceutical Atlas, which includes the option to download figures and data. The Pharmaceutical Atlas 2023: - All analyses are based on the concept of daily doses and reimbursement prices. - The statutory discounts and rebates granted by manufacturers and pharmacies are taken into account to clearly illustrate the effects of health policy regulation on expenditure. - For the year 2022, changes in consumption and price, as well as structural shifts compared to 2021, are examined. - Analyses related to the Act on the Restructuring of the Pharmaceutical Market (AMNOG) are presented in tabular overviews of the benefit assessment procedures.